High-dose (80 mg) simvastatin is efficacious in both reducing low-density lipoprotein cholesterol (-48%) and triglyceride (-26%) levels and in elevating high-density lipoprotein cholesterol (+ 13%) levels in a large cohort of patients with familial hypercholesterolemia. No tachyphylaxis was seen during a 2-year treatment period, and therapy with simvastatin 80 mg was well tolerate
Aim. Patients with heterozygous familial hypercholesterolemia (FH) have an increased risk of prematu...
<p>Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-den...
Familial hypercholesterolemia Is the most common genetic disease in the world. It is characterized b...
The efficacy and tolerability of low doses of simvastatin (10 mg daily) were evaluated in a double-b...
Objective To determine the efficacy of statin treatment on risk of coronary heart disease in patient...
Background-A multicenter, randomized, double-blind, placebo-controlled study was conducted to evalua...
Simvastatin (MK 733), a new competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase...
Statins decrease low-density lipoprotein cholesterol (LDL-C), and additionally, reduce triglycerides...
This study was conducted to evaluate whether an increase in simvastatin and pravastatin dosage can p...
Maximal doses of potent statins are the basement of treatment of familial hypercholesterolemia (FH)....
Objective: To determine the efficacy of statin treatment on risk of coronary heart disease in patien...
We compared atorvastatin with simvastatin-based therapies in a prospective observational study of 20...
This study was a I-year clinical study on 16 (7 males and 9 females) pediatric patients with heteroz...
Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autos...
The effect of diet on plasma lipids and lipoproteins was examined in 19 patients with familial hyper...
Aim. Patients with heterozygous familial hypercholesterolemia (FH) have an increased risk of prematu...
<p>Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-den...
Familial hypercholesterolemia Is the most common genetic disease in the world. It is characterized b...
The efficacy and tolerability of low doses of simvastatin (10 mg daily) were evaluated in a double-b...
Objective To determine the efficacy of statin treatment on risk of coronary heart disease in patient...
Background-A multicenter, randomized, double-blind, placebo-controlled study was conducted to evalua...
Simvastatin (MK 733), a new competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase...
Statins decrease low-density lipoprotein cholesterol (LDL-C), and additionally, reduce triglycerides...
This study was conducted to evaluate whether an increase in simvastatin and pravastatin dosage can p...
Maximal doses of potent statins are the basement of treatment of familial hypercholesterolemia (FH)....
Objective: To determine the efficacy of statin treatment on risk of coronary heart disease in patien...
We compared atorvastatin with simvastatin-based therapies in a prospective observational study of 20...
This study was a I-year clinical study on 16 (7 males and 9 females) pediatric patients with heteroz...
Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autos...
The effect of diet on plasma lipids and lipoproteins was examined in 19 patients with familial hyper...
Aim. Patients with heterozygous familial hypercholesterolemia (FH) have an increased risk of prematu...
<p>Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-den...
Familial hypercholesterolemia Is the most common genetic disease in the world. It is characterized b...